Gamida Cell Ltd. - Ordinary Shares (GMDA) Social Stream
GAMIDA CELL LTD (GMDA) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering GMDA.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-01 | 4 | $27 | $11 | $18.4 | $1.32 | 1293.94% |
| 2021-11-16 | 5 | $22 | $11 | $15 | $1.32 | 1036.36% |
| 2022-03-24 | 5 | $22 | $11 | $14.6 | $1.32 | 1006.06% |
| 2022-04-26 | 6 | $22 | $11 | $14.6 | $1.32 | 1006.06% |
| 2022-08-02 | 6 | $22 | $6 | $13.2 | $1.32 | 900% |
| 2022-08-16 | 5 | $22 | $6 | $13.2 | $1.32 | 900% |
| 2022-09-12 | 5 | $22 | $8 | $13.6 | $1.32 | 930.3% |
| 2022-09-30 | 5 | $22 | $8 | $13 | $1.32 | 884.85% |
| 2022-10-02 | 5 | $22 | $7 | $12.8 | $1.32 | 869.7% |
| 2022-11-15 | 5 | $22 | $7 | $13.25 | $1.32 | 903.79% |
| 2022-11-22 | 5 | $22 | $7 | $12 | $1.32 | 809.09% |
| 2023-02-21 | 5 | $22 | $7 | $11.75 | $1.32 | 790.15% |
The Trend in the Analyst Price Target
GMDA's average price target has moved down $3.25 over the prior 15 months.
GMDA reports an average of 551.13% for its upside potential over the past 48 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-03-24 | 5 | 22 | 11 | 14.6 | 4.34 | 236.41% |
| 2022-08-10 | 5 | 22 | 6 | 13.2 | 2.64 | 400% |
| 2022-09-12 | 5 | 22 | 8 | 13.6 | 2.67 | 409.36% |
| 2022-11-15 | 5 | 22 | 7 | 12.0 | 1.90 | 531.58% |
| 2022-11-22 | 5 | 22 | 7 | 12.0 | 1.55 | 674.19% |
GMDA Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.2 | 4 | 1 | 0 | 0 | 0 | 5 |
The Trend in the Broker Recommendations
Over the past 153 days, GMDA's average broker recommendation rating improved by 0.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for GMDA as an investment opportunity.
- GMDA has a greater upside potential (average analyst target price relative to current price) than 1150.07% of all US stocks.
- In the context of all US stocks, GAMIDA CELL LTD's variance in analysts' estimates is lower than -945.7% of them.
- GAMIDA CELL LTD's average analyst price target is greater than 307.44% of Healthcare stocks.
- In terms of how GAMIDA CELL LTD fares relative to Healthcare stocks, note that its number of analysts covering the stock is higher than 371.39% of that group.
In the Pharmaceutical Products industry, IMTX, GRTS, and STRO are the three stocks most similar to GAMIDA CELL LTD regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is GMDA a Buy, Hold or Sell? See the POWR Ratings now!